Statistics at a Glance
At a Glance
Estimated New Cases in 2020 9,610
% of All New Cancer Cases 0.5%
Estimated Deaths in 2020 440
% of All Cancer Deaths 0.1%
|Year||Rate of New Cases — SEER 9||Rate of New Cases — SEER 13||Death Rate — U.S.||5-Year Relative Survival — SEER 9|
|Observed||Modeled Trend||Observed||Modeled Trend||Observed||Modeled Trend||Observed||Modeled Trend|
New cases come from SEER 13. Deaths come from U.S. Mortality.
All Races, Males. Rates are Age-Adjusted.
Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software.
New cases are also referred to as incident cases in other publications. Rates of new cases are also referred to as incidence rates.
Rate of New Cases and Deaths per 100,000: The rate of new cases of testicular cancer was 5.9 per 100,000 men per year. The death rate was 0.3 per 100,000 men per year. These rates are age-adjusted and based on 2013–2017 cases and deaths.
Lifetime Risk of Developing Cancer: Approximately 0.4 percent of men will be diagnosed with testicular cancer at some point during their lifetime, based on 2015–2017 data.
Prevalence of This Cancer: In 2017, there were an estimated 269,769 men living with testicular cancer in the United States.
How Many People Survive 5 Years Or More after Being Diagnosed with Testicular Cancer?
Relative survival statistics compare the survival of patients diagnosed with cancer with the survival of people in the general population who are the same age, race, and sex and who have not been diagnosed with cancer. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.
Based on data from SEER 18 2010–2016. Gray figures represent those who have died from testicular cancer. Green figures represent those who have survived 5 years or more.
Survival by Stage
Cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. In general, if the cancer is found only in the part of the body where it started it is localized (sometimes referred to as stage 1). If it has spread to a different part of the body, the stage is regional or distant. The earlier testicular cancer is caught, the better chance a person has of surviving five years after being diagnosed. For testicular cancer, 68.0% are diagnosed at the local stage. The 5-year relative survival for localized testicular cancer is 99.0%.
|Stage||Percent of Cases||5-Year Relative Survival|
Confined to Primary Site
Spread to Regional Lymph Nodes
Cancer Has Metastasized
SEER 18 2010–2016, All Races, Males by SEER Summary Stage 2000
New Cases and Deaths
How Common Is This Cancer?
Compared to other cancers, testicular cancer is rare.
|Rank||Common Types of Cancer||Estimated New
|1.||Breast Cancer (Female)||276,480||42,170|
|2.||Lung and Bronchus Cancer||228,820||135,720|
|5.||Melanoma of the Skin||100,350||6,850|
|8.||Kidney and Renal Pelvis Cancer||73,750||14,830|
Testicular cancer represents 0.5% of all new cancer cases in the U.S.
In 2020, it is estimated that there will be 9,610 new cases of testicular cancer and an estimated 440 people will die of this disease.
Who Gets This Cancer?
Testicular cancer is most common in young adults. The rate of new cases of testicular cancer was 5.9 per 100,000 men per year based on 2013–2017 cases, age-adjusted.
|American Indian/Alaska Native||5.2|
|All Races||Sex-specific cancer type|
|American Indian/Alaska Native|
SEER 21 2013–2017, Age-Adjusted
|Age Range||Percent of New Cases|
Testicular cancer is most frequently diagnosed among men aged 20–34.
SEER 21 2013–2017, All Races, Males
Who Dies From This Cancer?
The death rate was 0.3 per 100,000 men per year based on 2013–2017, age-adjusted.
|American Indian/Alaska Native||0.4|
|All Races||Sex-specific cancer type|
|American Indian/Alaska Native|
U.S. 2013–2017, Age-Adjusted
|Age Range||Percent of Deaths|
The percent of testicular cancer deaths is highest among men aged 20–34.
U.S. 2013–2017, All Races, Males
Trends in Rates
Changes Over Time
Keeping track of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.
Using statistical models for analysis, age-adjusted rates for new testicular cancer cases have been rising on average 0.8% each year over the last 10 years. Age-adjusted death rates have been stable over 2008–2017. 5-year relative survival trends are shown below.
More About This Cancer
Cancer and the Testis
Figure: Anatomy of the male reproductive and urinary systems; drawing shows front and side views of ureters, lymph nodes, rectum, bladder, prostate gland, vas deferens, urethra, penis, testicles, seminal vesicle, and ejaculatory duct.
Testicularcancer forms in tissues of one or both testicles. Most testicular cancers begin in germ cells (cells that make sperm) and are called testicular germ cell tumors.
Here are some resources for learning more about testicular cancer.
- More about risk factors for testicular cancer
- More about symptoms and diagnosis of testicular cancer
- More about treatment options for testicular cancer
- More about clinical trials
- More about cancer prevention
All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within:
Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2017, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2017/, based on November 2019 SEER data submission, posted to the SEER web site, April 2020.
All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.
SEER Cancer Stat Facts: Testicular Cancer. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/testis.html
These stat facts focus on population statistics that are based on the U.S. population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse the SEER Cancer Statistics Review. To see statistics for a specific state, go to the State Cancer Profiles.
The statistics presented in these stat facts are based on the most recent data available, most of which can be found in the SEER Cancer Statistics Review. In some cases, different year spans may be used. Estimates for the current year are based on past data.
Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.